Read + Share
Amedeo Smart
Independent Medical Education
Bejjani AC, Finn RS. Hepatocellular Carcinoma: Pick the Winner-Tyrosine Kinase Inhibitor Versus Immuno-oncology Agent-Based Combinations. J Clin Oncol 2022 Jun 1:JCO2102605. doi: 10.1200/JCO.21.02605.PMID: 35649192
Email
LinkedIn
Facebook
Twitter
Privacy Policy